People · Operator
Named in public records as an officer, director or promoter · active 2011–2011 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Neotract Inc | — | Other Health Care | Series C | $117.5M | $293.0M | 2011 |
Christopher W. Rowland at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Christopher W. Rowland on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Anderson | 1 | 24 |
| Ryan Drant | 1 | 24 |
| John Nehra | 1 | 11 |
| Joshua Makower | 1 | 10 |
| ROBERT CROCE | 1 | 7 |
| Robert W. Croce | 1 | 7 |
| Robert K. Anderson | 1 | 6 |
| David Amerson | 1 | 5 |
| William Facteau | 1 | 5 |
| ROGER GUIDI | 1 | 5 |
| Joshua W. Makower | 1 | 4 |
| Kadir Kadhiresan | 1 | 4 |
| Ryan W. Drant | 1 | 4 |
| Maria Sainz | 1 | 3 |
| William M. Facteau | 1 | 2 |
| Theodore Lamson | 1 | 2 |
| Frank M. Torti | 1 | 1 |
| Theodore C. Lamson | 1 | 1 |
| Joshua K. Makower | 1 | 1 |
| Roger W. Guidi | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.